Detail of "69227-93-6"

Reference

Metabolism of orally administered alkyl b-glycosides in the mouse

Metabolism of orally administered alkyl b-glycosides in the mouse. Weber, Nikolaus; Benning, Hildegard (Inst. Biochem. Technol., H. P. Kaufmann Inst., Muenster D-4400, Fed. Rep. Ger.Several reagents with their cas registry numbers 29836-26-8 and 75319-63-0 are used here.). J. Nutr., 114(2), 247-54 (English) 1984. CODEN: JONUAI. ISSN: 0022-3166. DOCUMENT TYPE: Journal CA Section: 17 (Food and Feed Chemistry) Section cross-reference(s): 4 The metab. of 14C-labeled octyl b-D-glucoside [29836-26-8], dodecyl b-D-maltoside [69227-93-6] and hexadecyl b-D-glucoside [75319-63-0] was studied after oral administration to mice. The b-glycosidic bond was rapidly hydrolyzed in intestine and liver. The cleavage products, sugars and long-chain alcs., entered the pathways of lipid and carbohydrate metab. It appears that alkyl b-glycosides are suitable as additives in food and feed. .

Stabilizing alkyl glycoside compositions

All Rights Reserved. Stabilizing alkyl glycoside compositions. Pert, Candance B.; Ruff, Michael R. (Rapid Pharmaceuticals, LLC, USA). PCT Int. Appl. WO 2007002465 A2 4 Jan 2007, 73pp. DESIGNATED STATES: W: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC; RW: AT, BE, BF, BJ, CF, CG, CH, CI, CM, CY, DE, DK, ES, FI, FR, GA, GB, GR, IE, IS, IT, LU, MC, ML, MR, NE, NL, PT, SE, SN, TD, TG, TR. (English). (World Intellectual Property Organization). CODEN: PIXXD2. APPLICATION: WO 2006-US24576 23 Jun 2006. PRIORITY: US 2005-693089P 23 Jun 2005. DOCUMENT TYPE: Patent CA Section: 63 (Pharmaceuticals) The present invention relates to alkyl glycoside-contg. compns. and methods for increasing the stability, reducing the aggregation and immunogenicity, increasing the biol. activity, and reducing or preventing fibrillar formation of a peptide, polypeptide, or variant thereof, e.In this experiment, several chemicals are used like 69227-93-6 and 37221-79-7 g., insulin and Peptide T or analog thereof. Insulin in the presence of an alkyl glycoside in the formulations was longer-acting than the insulin without the glycoside. .